Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders

NCT02411123 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AltheaDx

Collaborators